Alpha 2.0
Login Register
» Authors » Jeremie Prevost

Jeremie Prevost

Explore the profile of Jeremie Prevost including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 92
Citations 2661
Followers 0
Related Specialties
Microbiology
Biology
Infectious Diseases
Top 10 Co-Authors
Andres Finzi
Jonathan Richard
Halima Medjahed
Marzena Pazgier
Shilei Ding
Sai Priya Anand
Guillaume Beaudoin-Bussieres
Romain Gasser
Mehdi Benlarbi
Gabrielle Gendron-Lepage
Published In
J Virol
bioRxiv
mBio
Cell Rep
Cell Host Microbe
Affiliations
Soon will be listed here.
Recent Articles
1.
Sin Nombre Virus as Unlikely Reverse Zoonotic Threat
Prevost J, Tailor N, Leung A, Warner B, Safronetz D
Emerg Infect Dis . 2025 Feb; 31(2):385-388. PMID: 39983702
We inoculated clinical materials into deer mice to attempt isolation of Sin Nombre virus. We did not observe productive infection in the natural rodent reservoir. Genomic comparisons between rodent reservoirs...
2.
Dissecting immunological mechanisms underlying influenza viral nucleoprotein-induced mucosal immunity against diverse viral strains
Zhang W, Sloan A, Prevost J, Tamming L, Raman S, Pfeifle A, et al.
Emerg Microbes Infect . 2024 Nov; 13(1):2427792. PMID: 39508450
The nucleoprotein (NP) of type A influenza virus (IAV) is highly conserved across all virus strains, making it an attractive candidate antigen for universal vaccines. While various studies have explored...
3.
CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies
Richard J, Sannier G, Zhu L, Prevost J, Marchitto L, Benlarbi M, et al.
mBio . 2024 Oct; 15(11):e0182724. PMID: 39373535
Importance: Antibody-dependent cellular cytotoxicity (ADCC) represents an effective immune response for clearing virally infected cells, making ADCC-mediating antibodies promising therapeutic candidates for HIV-1 cure strategies. Broadly neutralizing antibodies (bNAbs) target...
4.
The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity
Marchitto L, Richard J, Prevost J, Tauzin A, Yang D, Chiu T, et al.
J Virol . 2024 Sep; 98(10):e0101624. PMID: 39248460
The majority of naturally elicited antibodies against the HIV-1 envelope glycoproteins (Env) are non-neutralizing (nnAbs) because they are unable to recognize the Env trimer in its native "closed" conformation. Nevertheless,...
5.
Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates
Prevost J, Sloan A, Deschambault Y, Tailor N, Tierney K, Azaransky K, et al.
Antiviral Res . 2024 Sep; 231:105995. PMID: 39243894
While historically confined to endemic areas, Monkeypox virus (MPXV) infection has increasingly garnered international attention due to sporadic outbreaks in non-endemic countries in the last two decades and its potential...
6.
Three families of CD4-induced antibodies are associated with the capacity of plasma from people living with HIV to mediate ADCC in the presence of CD4-mimetics
Tauzin A, Marchitto L, Belanger E, Benlarbi M, Beaudoin-Bussieres G, Prevost J, et al.
J Virol . 2024 Sep; 98(10):e0096024. PMID: 39230306
Importance: There are several reasons that make it difficult to target the HIV reservoir. One of them is the capacity of infected cells to prevent the recognition of HIV-1 envelope...
7.
Conformational dynamics of the HIV-1 envelope glycoprotein from CRF01_AE is associated with susceptibility to antibody-dependent cellular cytotoxicity
Diaz-Salinas M, Chatterjee D, Nayrac M, Medjahed H, Prevost J, Pazgier M, et al.
bioRxiv . 2024 Sep; PMID: 39229074
The HIV-1 envelope glycoprotein (Env) is expressed at the surface of infected cells and as such can be targeted by non-neutralizing antibodies (nnAbs) that mediate antibody-dependent cellular cytotoxicity (ADCC). Previous...
8.
Structure and inhibition of SARS-CoV-2 spike refolding in membranes
Grunst M, Qin Z, Dodero-Rojas E, Ding S, Prevost J, Chen Y, et al.
Science . 2024 Aug; 385(6710):757-765. PMID: 39146425
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein binds the receptor angiotensin converting enzyme 2 (ACE2) and drives virus-host membrane fusion through refolding of its S2 domain. Whereas...
9.
The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity
Marchitto L, Richard J, Prevost J, Tauzin A, Yang D, Chiu T, et al.
bioRxiv . 2024 Jun; PMID: 38895270
The majority of naturally-elicited antibodies against the HIV-1 envelope glycoproteins (Env) are non-neutralizing (nnAbs), because they are unable to recognize the Env timer in its native "closed" conformation. Nevertheless, it...
10.
Three families of CD4-induced antibodies are associated with the capacity of plasma from people living with HIV to mediate ADCC in presence of CD4-mimetics
Tauzin A, Marchitto L, Belanger E, Benlarbi M, Beaudoin-Bussieres G, Prevost J, et al.
medRxiv . 2024 Jun; PMID: 38883797
CD4-mimetics (CD4mcs) are small molecule compounds that mimic the interaction of the CD4 receptor with HIV-1 envelope glycoproteins (Env). Env from primary viruses normally samples a "closed" conformation which occludes...